Original Research
Published on 30 Apr 2024
MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon
in Cancer Molecular Targets and Therapeutics
- 2,521 views
Original Research
Published on 30 Apr 2024
in Cancer Molecular Targets and Therapeutics
Review
Published on 01 Nov 2013
in Gastrointestinal Sciences
Original Research
Published on 06 Oct 2021
in Molecular and Cellular Pathology
Original Research
Published on 03 Nov 2021
in Gastroenterology
Original Research
Published on 05 Nov 2020
in Cell Adhesion and Migration
Original Research
Published on 02 Nov 2021
in Molecular and Cellular Pathology
Original Research
Published on 06 Sep 2021
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 11 Nov 2020
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 05 Dec 2018
in Molecular and Cellular Oncology
Original Research
Published on 09 Feb 2023
in Radiation Oncology
Original Research
Published on 09 Oct 2020
in Low-Temperature Plasma Physics
Brief Research Report
Published on 20 Jun 2022
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Published on 10 Jan 2023
in Molecular and Cellular Oncology
Original Research
Published on 30 Jul 2024
in Ethnopharmacology
Original Research
Published on 05 Jun 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 19 Feb 2018
in Pharmacology of Anti-Cancer Drugs